Yente Florine Niké Boelens

Yente Florine Niké Boelens

Auto-generated profile, based on publicly available information

Yente Florine Niké Boelens

Department of Intensive Care Medicine & Research, Gelderse Vallei Hospital, Willy Brandtlaan 10, 6716 RP Ede, the Netherlands; Division of Human Nutrition and Health, Nutritional Biology, Wageningen University & Research, HELIX (Building 124), Stippeneng 4, 6708 WE Wageningen, the Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Clinical Nutrition
Verified
Journal Article
Open access
MPMichelle Carmen Paulus
Michelle Carmen Paulus
KKKouw Kouw
Kouw Kouw
YBYente Florine Niké Boelens
Yente Florine Niké Boelens
AHAnoek Jacqueline Hubertine Hermans
Anoek Jacqueline Hubertine Hermans
BSBert Strookappe
Bert Strookappe
AZArthur Raymond Hubert van Zanten
Arthur Raymond Hubert van Zanten
Dietary protein supplementation may benefit physical outcomes in post-intensive care unit (ICU) patients suffering ICU-acquired weakness (ICU-AW). This study examines the impact of a six-week protein supplementation compared to an isocaloric carbohydrate on physical functioning outcomes in post-ICU patients with a follow-up of 12 weeks after ICU discharge. This paper presents descriptive data, feasibility outcomes, and the barriers faced while conducting this nutritional intervention study in post-ICU patients. This two-arm, randomised, double-blind controlled intervention trial involved adult patients (≥18 y) who were admitted to the ICU for ≥72 h with moderate ICU-AW (Medical Research Council (MRC) score 24-48). Patients were randomly assigned to receive 22 g of collagen peptides supplementation or an isocaloric carbohydrate twice daily. The primary outcome was a composite score for physical functioning comprising handgrip strength, leg muscle strength, arm muscle strength, and exercise capacity, adjusted for age, sex, and body weight. Secondary endpoints included nutritional intake and biomarkers, scores in other post-intensive care syndrome (PICS) domains, and mortality rates. Descriptive data is presented, no between-intervention group analyses were conducted due to incomplete sample size. A total of 900 patients were screened for eligibility to participate in the study, of whom 59 met the requisite criteria between April 2022 and December 2023. The most common reasons for exclusion were treatment limitations, diabetes mellitus, or an MRC score 48. Of the 59 patients deemed eligible, 15 patients were included to participate in the study. Due to the slow inclusion rate, the study was terminated early (at ∼20 % of anticipated sample size). At baseline (ICU discharge), patients initially had lower physical scores than reference values but showed improved (higher) scores at three months post-ICU discharge. Differences between the groups regarding the primary outcome (composite score of physical functioning) could not be identified due to early termination. Factors affecting the feasibility of nutrition research in post-ICU patients were identified, including slow patient recruitment rates, low adherence to the intervention, and the inability to complete outcome assessments. Patients exhibited initial physical functioning scores below the reference values yet demonstrated substantial physical recuperation by the 12-week mark following their ICU discharge in both groups. Patients exhibited lower scores in all domains of PICS compared to reference values, emphasising the necessity for further investigation into the potential role of nutrition interventions in preventing and alleviating PICS symptoms. Furthermore, this study describes the factors affecting the feasibility of post-ICU intervention studies and provides recommendations for future studies on effective design and conduction of studies to address PICS (This study was supported by Rousselot; Confucius ClinicalTrials.gov number, NCT05405764).

19 October 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
YBYente Fn. Boelens
Yente Fn. Boelens
BSBert Strookappe
Bert Strookappe
EVEmmelyne Vasse
Emmelyne Vasse
MMMarco Mensink
Marco Mensink
AZArthur Rh. van Zanten
Arthur Rh. van Zanten
Patients discharged from the Intensive Care Unit (ICU) frequently suffer from ICU-acquired weakness because of immobilization and massive inflammation-induced muscle mass loss. Consequently, rehospitalization, reduced quality of life (QoL), increased disabilities, and higher post-ICU mortality is observed. Exercise rehabilitation and optimal nutrition, particularly protein intake, are pivotal to regaining muscle mass and function. Studies have shown that protein requirements in the post-ICU phase are often unmet. Furthermore, protein supplementation in other patient groups has shown beneficial effects. However, a study on protein supplementation during the post-ICU period is lacking. This study aims to investigate the effect of a six-week intervention of daily porcine protein supplementation versus an isocaloric control (maltodextrin) on functional outcomes in the post-ICU period in patients with moderately severe ICU-acquired weakness. 72 post-ICU patients with moderately severe ICU-acquired weakness of Hospital Gelderse Vallei will be randomly assigned to either the intervention or the control group (36 per arm). The intervention group receives a porcine protein supplement twice a day. The control group receives a maltodextrin supplement twice a day. The intervention starts on the first day in the general ward and lasts 42 days (6 weeks). The primary outcome is the between-group difference in physical function at hospital discharge (t;=2), the end of the intervention (t;=3, day 42), and the 3-month follow-up (t;=4) expressed as a composite score consisting of handgrip strength, muscle strength leg, muscle strength arm and exercise capacity. Secondary outcomes encompass physical function, QoL, Activity of daily living (ADL), and plasma amino acids concentrations. Lastly, ICU readmission after ICU discharge, hospital readmission after hospital discharge, and overall survival status will be considered. Linear mixed models will be used to test the treatment effect for the primary and secondary outcome measures. This trial will be the first to investigate porcine protein supplementation compared with carbohydrate supplementation in the post-ICU period aiming to improve functional outcomes of ICU survivors with moderately severe ICU-acquired weakness. The study has been registered at ClinicalTrials.gov. Number: NCT05405764.